improved

Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025

March 01, 2025 12:45 ET  | Source: Celldex Therapeutics, Inc. - Greatly improved patient quality of life and reduced disease…

2 weeks ago

Artelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex

February 14, 2025 09:00 ET  | Source: Artelo Biosciences SOLANA BEACH, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences,…

4 weeks ago

Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Extend provides organizations with a cost-effective, non-disruptive, reliable, and compliant mobile communications solution that enables access to essential business…

2 months ago

Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Extend provides organizations with a cost-effective, non-disruptive, reliable, and compliant mobile communications solution that enables access to essential business…

2 months ago

Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Extend provides organizations with a cost-effective, non-disruptive, reliable, and compliant mobile communications solution that enables access to essential business…

2 months ago

Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Extend provides organizations with a cost-effective, non-disruptive, reliable, and compliant mobile communications solution that enables access to essential business…

2 months ago

Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Extend provides organizations with a cost-effective, non-disruptive, reliable, and compliant mobile communications solution that enables access to essential business…

2 months ago

Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Extend provides organizations with a cost-effective, non-disruptive, reliable, and compliant mobile communications solution that enables access to essential business…

2 months ago

New Phase IIIB data shows Novartis Fabhalta improved hemoglobin levels in adult patients with paroxysmal nocturnal hemoglobinuria who switched from anti-C5 therapy

In the Phase IIIB APPULSE-PNH study, oral Fabhalta® (iptacopan) improved the average hemoglobin (Hb) level versus baseline in adult patients…

3 months ago